176 related articles for article (PubMed ID: 37210410)
1. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database.
Gupta A; Omeogu C; Islam JY; Joshi A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
Sci Rep; 2023 May; 13(1):8190. PubMed ID: 37210410
[TBL] [Abstract][Full Text] [Related]
2. Association of area-level socioeconomic status and non-small cell lung cancer stage by race/ethnicity and health care-level factors: Analysis of the National Cancer Database.
Gupta A; Omeogu CH; Islam JY; Joshi AR; Akinyemiju TF
Cancer; 2022 Aug; 128(16):3099-3108. PubMed ID: 35719098
[TBL] [Abstract][Full Text] [Related]
3. Association Between Food and Drug Administration Approval and Disparities in Immunotherapy Use Among Patients With Cancer in the US.
Ermer T; Canavan ME; Maduka RC; Li AX; Salazar MC; Kaminski MF; Pichert MD; Zhan PL; Mase V; Kluger H; Boffa DJ
JAMA Netw Open; 2022 Jun; 5(6):e2219535. PubMed ID: 35771575
[TBL] [Abstract][Full Text] [Related]
4. Racial Differences in Survival Among Advanced-stage Non-small-Cell Lung Cancer Patients Who Received Immunotherapy: An Analysis of the US National Cancer Database (NCDB).
Gupta A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
J Immunother; 2022 Feb-Mar 01; 45(2):132-137. PubMed ID: 34747372
[TBL] [Abstract][Full Text] [Related]
5. Racial and ethnic inequities of palliative care use among advanced Non-Small cell lung cancer patients in the US.
Islam JY; Braithwaite D; Zhang D; Guo Y; Tailor TD; Akinyemiju T
Cancer Med; 2023 Apr; 12(7):8567-8580. PubMed ID: 36533434
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic and Socioeconomic Disparities in Management of Incident Paroxysmal Atrial Fibrillation.
Eberly LA; Garg L; Yang L; Markman TM; Nathan AS; Eneanya ND; Dixit S; Marchlinski FE; Groeneveld PW; Frankel DS
JAMA Netw Open; 2021 Feb; 4(2):e210247. PubMed ID: 33635328
[TBL] [Abstract][Full Text] [Related]
7. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
[TBL] [Abstract][Full Text] [Related]
8. Association Between Demographic and Socioeconomic Factors and Diagnosis of Advanced Non-small Cell Lung Cancer: An Analysis of the National Cancer Database.
Verplancke KB; Keirns DL; McMahon K; Creech ZA; Truong GT; Silberstein PT; Dahl MB
Cureus; 2023 Aug; 15(8):e44351. PubMed ID: 37779816
[TBL] [Abstract][Full Text] [Related]
9. Association of area-level mortgage denial and guideline-concordant non-small-cell lung cancer care and outcomes in the United States.
Fan Q; Hussaini SMQ; Barrow LCJ; Feliciano JL; Pollack CE; Yabroff KR; Nogueira L
Cancer Med; 2024 Feb; 13(3):e6921. PubMed ID: 38205942
[TBL] [Abstract][Full Text] [Related]
10. Is underutilization of adjuvant therapy in resected non-small-cell lung cancer associated with socioeconomic disparities?
Rodriguez-Quintero JH; Kamel MK; Jindani R; Zhu R; Friedmann P; Vimolratana M; Chudgar NP; Stiles B
Eur J Cardiothorac Surg; 2023 Dec; 64(6):. PubMed ID: 37952179
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer.
Hardy D; Liu CC; Xia R; Cormier JN; Chan W; White A; Burau K; Du XL
Cancer; 2009 May; 115(10):2199-211. PubMed ID: 19365824
[TBL] [Abstract][Full Text] [Related]
12. Persistence of racial disparities in early-stage lung cancer treatment.
Wolf A; Alpert N; Tran BV; Liu B; Flores R; Taioli E
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1670-1679.e4. PubMed ID: 30685165
[TBL] [Abstract][Full Text] [Related]
13. Eligibility Criteria for Lower Extremity Joint Replacement May Worsen Racial and Socioeconomic Disparities.
Wang AY; Wong MS; Humbyrd CJ
Clin Orthop Relat Res; 2018 Dec; 476(12):2301-2308. PubMed ID: 30303879
[TBL] [Abstract][Full Text] [Related]
14. Unequal racial distribution of immunotherapy for late-stage non-small cell lung cancer.
Chang A; Flores RM; Taioli E
J Natl Cancer Inst; 2023 Oct; 115(10):1224-1226. PubMed ID: 37421405
[TBL] [Abstract][Full Text] [Related]
15. Influence of Sociodemographic Factors on Treatment Decisions in Non-Small-Cell Lung Cancer.
Duma N; Idossa DW; Durani U; Frank RD; Paludo J; Westin G; Lou Y; Mansfield AS; Adjei AA; Go RS; Ailawadhi S
Clin Lung Cancer; 2020 May; 21(3):e115-e129. PubMed ID: 31570228
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic disparities in lung cancer treatment and outcomes persist within a single academic medical center.
Yorio JT; Yan J; Xie Y; Gerber DE
Clin Lung Cancer; 2012 Nov; 13(6):448-57. PubMed ID: 22512997
[TBL] [Abstract][Full Text] [Related]
17. Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003.
Steele CB; Pisu M; Richardson LC
J Natl Med Assoc; 2011 Aug; 103(8):711-8. PubMed ID: 22046848
[TBL] [Abstract][Full Text] [Related]
18. Neighborhood context and non-small cell lung cancer outcomes in Florida non-elderly patients by race/ethnicity.
Johnson AM; Johnson A; Hines RB; Mohammadi R
Lung Cancer; 2020 Apr; 142():20-27. PubMed ID: 32062478
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities.
Zhang D; Tailor TD; Kim C; Atkins MB; Braithwaite D; Akinyemiju T
J Immunother; 2021 Jun; 44(5):198-203. PubMed ID: 33758148
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparities in Overall Survival and Surgical Treatment for Early Stage Lung Cancer by Facility Type.
Merritt RE; Abdel-Rasoul M; D'Souza DM; Kneuertz PJ
Clin Lung Cancer; 2021 Sep; 22(5):e691-e698. PubMed ID: 33597104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
